Patent No. EP3800177 (titled "Fenfluramine Compositions And Methods Of Preparing The Same") was filed by Zogenix on Dec 20, 2016. The application was issued on Jan 29, 2025.
A method for preparing fenfluramine active pharmaceutical ingredient (API) with reduced levels of impurities, particularly trifluoromethyl regioisomers. The method involves hydrolyzing 2-(3-(trifluoromethyl)phenyl)acetonitrile to produce 2-(3-(trifluoromethyl)phenyl)acetic acid, reacting the acid with acetic anhydride to form 1-(3-(trifluoromethyl)phenyl)propan-2-one, and reductively aminating the ketone with ethylamine to produce fenfluramine. The resulting API has a purity profile of at least 90% fenfluramine, less than 0.2% 2-fenfluramine, less than 0.2% 4-fenfluramine, and less than 1% fenfluramine alcohol.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents